Cargando…
BRCA1-mutated and basal-like breast cancers have similar aCGH profiles and a high incidence of protein truncating TP53 mutations
BACKGROUND: Basal-like breast cancers (BLBC) are aggressive breast cancers for which, so far, no targeted therapy is available because they typically lack expression of hormone receptors and HER2. Phenotypic features of BLBCs, such as clinical presentation and early age of onset, resemble those of b...
Autores principales: | Holstege, Henne, Horlings, Hugo M, Velds, Arno, Langerød, Anita, Børresen-Dale, Anne-Lise, van de Vijver, Marc J, Nederlof, Petra M, Jonkers, Jos |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3002929/ https://www.ncbi.nlm.nih.gov/pubmed/21118481 http://dx.doi.org/10.1186/1471-2407-10-654 |
Ejemplares similares
-
Cross-species comparison of aCGH data from mouse and human BRCA1- and BRCA2-mutated breast cancers
por: Holstege, Henne, et al.
Publicado: (2010) -
KC-SMARTR: An R package for detection of statistically significant aberrations in multi-experiment aCGH data
por: de Ronde, Jorma J, et al.
Publicado: (2010) -
SIRAC: Supervised Identification of Regions of Aberration in aCGH datasets
por: Lai, Carmen, et al.
Publicado: (2007) -
aCGH-MAS: Analysis of aCGH by means of Multiagent System
por: De Paz, Juan F., et al.
Publicado: (2015) -
A multiplex PCR predictor for aCGH success of FFPE samples
por: van Beers, E H, et al.
Publicado: (2006)